330 results on '"Kern, Johannes S"'
Search Results
2. The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions
3. Management von bullösem Pemphigoid und Schleimhautpemphigoid
4. Evaluation and management of nail diseases.
5. The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab
6. A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
7. Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa
8. CXCL17 induces activation of human mast cells via MRGPRX2.
9. Cutaneous Pathology of the Head and Neck
10. Management of bullous pemphigoid and mucous membrane pemphigoid
11. Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival
12. A simple solution for habit‐tic nail deformity
13. Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)
14. Management von bullösem Pemphigoid und Schleimhautpemphigoid.
15. CAN-15-1348R-Supplementary Figure legends from Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression
16. CAN-15-1348R-Supplementary Figure-S1 from Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression
17. CAN-15-1348R-Supplementary materials and methods from Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression
18. CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa
19. Cutaneous Pathology of the Head and Neck
20. Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
21. Clinical and dermoscopic features of nail unit melanoma in an Australian nail clinic cohort.
22. Cutaneous Pathology of the Head and Neck
23. Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
24. Clinical and histopathological features of onychopapilloma in an Australian setting: A case series of 50 patients
25. Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa
26. Annular Flaccid Pustules on the Trunk
27. Evaluation and management of nail diseases.
28. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
29. Australian Teledermatology experience during COVID‐19
30. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
31. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid
32. S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoid
33. S2k-Leitlinie zur Diagnostik des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids
34. S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid
35. Vegetating plaques in a patient with a seizure disorder
36. Vegetierende Plaques bei einem Patienten mit Anfallserkrankung
37. Erythematöse Plaques mit zentrifugaler Ausbreitung, colleretteartiger Schuppung und Pusteln: Centrifugally spreading erythematous plaques with collarette scaling and pustules
38. Centrifugally spreading erythematous plaques with collarette scaling and pustules
39. De-escalation of anti-CD20 monoclonal antibody (Rituximab) protocols in Pemphigus Vulgaris ��� a systematic review
40. Collagen VII plays a dual role in wound healing
41. De-escalation of anti-CD20 monoclonal antibody (Rituximab) protocols in Pemphigus Vulgaris – a systematic review
42. Successful management of treatment resistant nail psoriasis with tildrakizumab
43. Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease
44. Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease
45. A casemix study of patients seen within an urban Aboriginal Health Service dermatology clinic over a five‐year period
46. Juckende eingetrübte Bläschen in den Körperfalten Pruritic intertriginous vesiculopustular eruption
47. Pruritic intertriginous vesiculopustular eruption
48. Insektenstichartige Reaktion bei einer Patientin mit chronisch lymphatischer Leukämie: Insect bite-like reaction in a patient with chronic lymphocytic leukemia
49. Insect bite-like reaction in a patient with chronic lymphocytic leukemia
50. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.